AstraZeneca PLC — Director's Dealing 2014

May 2, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1.				KEY INFORMATION
(a)		Identity of the person whose positions/dealings are being disclosed:						Wellington Management Company, LLP
(b)		Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient
(c)		Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree						AstraZeneca PLC
(d)		If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e)		Date position held/dealing undertaken:						01 May 2014
(f)		Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?						YES
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)				Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:						Ordinary Shares (GB0009895292) and ADRs (US0463531089)
						Interests
						Number				%
(1)		Relevant securities owned and/or controlled:				68,380,208 shares				5.42 %
(2)		Derivatives (other than options):
(3)		Options and agreements to purchase/sell:
		Total				68,380,208 shares				5.42 %
(b)				Rights to subscribe for new securities (including directors’ and other executive options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.		DEALINGS
(a)		Purchases and sales
Class of relevant security																Purchase/sale												Number of securities
Ordinary Shares (GB0009895292)																Purchase												4,209 shares
Ordinary Shares (GB0009895292)																Purchase												1,159 shares
Ordinary Shares (GB0009895292)																Sale												78,652 shares
ADRs (US0463531089)																Purchase												13,400 Depository Receipts (representing 13,400 shares on a converted basis)
ADRs (US0463531089)																Purchase												765 Depository Receipts (representing 765 shares on a converted basis)
ADRs (US0463531089)																Sale												4,320 Depository Receipts (representing 4,320 shares on a converted basis)
ADRs (US0463531089)																Sale												4,330 Depository Receipts (representing 4,330 shares on a converted basis)
ADRs (US0463531089)																Sale												12,990 Depository Receipts (representing 12,990 shares on a converted basis)
(b)		Derivatives transactions (other than options)
Class of relevant security								Product description e.g. CFD																Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position
(c)		Options transactions in respect of existing securities
(i)		Writing, selling, purchasing or varying
Class of relevant security				Product description e.g. call option								Writing, purchasing, selling, varying etc.								Number of securities to which option relates								Exercise price per unit
(ii)		Exercising
Class of relevant security																Product description e.g. call option												Number of securities
(d)		Other dealings (including subscribing for new securities)
Class of relevant security																Nature of dealing e.g. subscription, conversion												Details

4.		OTHER INFORMATION
(a)		Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state “none”
None
(b)		Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None
(c)		Attachments
Is a Supplemental Form 8 attached?
Date of disclosure
Contact name
Telephone number

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk . The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel?s website at www.thetakeoverpanel.org.uk .